China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
Looking for a comprehensive and reliable source of stock market news? Benzinga creates actionable, market-moving stock news content that is all written in-house. Benzinga’s editorial team cuts through ...
Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Arthur Gies Arthur Gies is an editor for Wirecutter's tech coverage. He's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results